Author:
Serakinci Nedime,Tulay Pinar,Kalkan Rasime
Publisher
Springer International Publishing
Reference147 articles.
1. Abdul-Ghani, R., Ohana, P., Matouk, I., Ayesh, S., Ayesh, B., Laster, M., Bibi, O., Giladi, H., Molnar-Kimber, K., Sughayer, M. A., De Groot, N., & Hochberg, A. (2000). Use of transcriptional regulatory sequences of telomerase (hTER and hTERT) for selective killing of cancer cells. Molecular Therapy, 2, 539–544.
2. Aboody, K. S., Najbauer, J., & Danks, M. K. (2008). Stem and progenitor cell-mediated tumor selective gene therapy. Gene Therapy, 15, 739–752.
3. Barcellos-De-Souza, P., Gori, V., Bambi, F., & Chiarugi, P. (2013). Tumor microenvironment: Bone marrow-mesenchymal stem cells as key players. Biochimica et Biophysica Acta, 1836, 321–335.
4. Barkholt, L., Flory, E., Jekerle, V., Lucas-Samuel, S., Ahnert, P., Bisset, L., Buscher, D., Fibbe, W., Foussat, A., Kwa, M., Lantz, O., Maciulaitis, R., Palomaki, T., Schneider, C. K., Sensebe, L., Tachdjian, G., Tarte, K., Tosca, L., & Salmikangas, P. (2013). Risk of tumorigenicity in mesenchymal stromal cell-based therapies–bridging scientific observations and regulatory viewpoints. Cytotherapy, 15, 753–759.
5. Barrilleaux, B. L., Fischer-Valuck, B. W., Gilliam, J. K., Phinney, D. G., & O’connor, K. C. (2010). Activation of CD74 inhibits migration of human mesenchymal stem cells. In Vitro Cellular & Developmental Biology Animal, 46, 566–572.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献